Chinese herbal medicine (CHM), with a range of pharmacological and molecular targets, has unique advantages in the comprehensive treatment of colorectal cancer (CRC); however, its clinical application remains limited owing to undetermined anti-CRC mechanisms. Recent studies have shown that gut microbes mediate the intestinal barrier, metabolism, and immunity, which, in turn, affect CRC initiation, progression, and CHM therapy. Here, we summarize the mechanisms and clinical applications of the gut microbiota involved in CRC, together with the latest studies of CHM in CRC therapy and its anti-tumor molecular basis from the gut microbiota perspective. This review highlights the gut microbiota as a "bridge" to clarify the scientific of CHM in treating CRC. More efforts should be focused on how the gut microbiome interacts with CHM to elucidate the mechanism of action of CHM and provide a more applicable basis for CHM- and microbiota-related therapies for the treatment of CRC.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |